Secukinumab provides sustained pasdas related low disease activity in psoriatic arthritis: Two year results from the future 2 study

Category Primary study
JournalRheumatology (United Kingdom)
Year 2018
This article has no abstract
Epistemonikos ID: fc0061da9d60cebeadafef3b39cdc48d1eca96fb
First added on: Feb 09, 2025